ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
1 Year Est. Return
+28.09%
AUM
$67.5B
AUM Growth
+$10.9B
(+19%)
Holding
2,060
Top Buys
| 1 | +$19.7B | |
| 2 | +$729M | |
| 3 | +$33.1M | |
| 4 |
Erie Indemnity
ERIE
|
+$26.7M |
| 5 |
Becton Dickinson
BDX
|
+$26.1M |
Top Sells
| 1 | +$799M | |
| 2 | +$563M | |
| 3 | +$445M | |
| 4 |
Amazon
AMZN
|
+$321M |
| 5 |
Broadcom
AVGO
|
+$274M |
Sector Composition
| 1 | Technology | 23.92% |
| 2 | Consumer Staples | 7.6% |
| 3 | Consumer Discretionary | 6.94% |
| 4 | Communication Services | 6.66% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Utz Brands
UTZ
$648M
| $84.5K | ﹤0.01% |
10,674
-2,783
|
|
||
1727
Sabre
SABR
$696M
| $84K | ﹤0.01% |
57,940
-14,227
|
|
||
1728
Aquestive Therapeutics
AQST
$504M
| $84K | ﹤0.01% |
20,239
-4,243
|
|
||
|
RZLV
1729
Rezolve AI
RZLV
$1.19B
| $82.4K | ﹤0.01% |
32,189
-493
|
|
||
1730
Ardagh Metal Packaging
AMBP
$2.41B
| $81.9K | ﹤0.01% |
20,224
-5,274
|
|
||
1731
Weave Communications
WEAV
$479M
| $81.8K | ﹤0.01% |
17,710
-904
|
|
||
1732
ReNew
RNW
$2.33B
| $81.4K | ﹤0.01% |
17,773
+2,542
|
|
||
|
TRTX
1733
TPG RE Finance Trust
TRTX
$649M
| $81K | ﹤0.01% |
10,365
-1,963
|
|
||
1734
SunCoke Energy
SXC
$765M
| $80.2K | ﹤0.01% |
12,317
-4,198
|
|
||
1735
Prime Medicine
PRME
$641M
| $79.9K | ﹤0.01% |
22,968
-3,190
|
|
||
1736
Allogene Therapeutics
ALLO
$749M
| $79.6K | ﹤0.01% |
32,638
-5,396
|
|
||
1737
Cytek Biosciences
CTKB
$541M
| $79.6K | ﹤0.01% |
18,216
-4,517
|
|
||
1738
PagerDuty
PD
$767M
| $79.2K | ﹤0.01% |
12,753
-3,571
|
|
||
1739
Rumble
RUM
$1.99B
| $78.9K | ﹤0.01% |
15,471
-3,963
|
|
||
1740
FTAI Infrastructure
FIP
$527M
| $78.5K | ﹤0.01% |
15,892
-4,142
|
|
||
1741
Sweetgreen
SG
$1.18B
| $77.9K | ﹤0.01% |
15,013
-3,913
|
|
||
1742
Solid Power
SLDP
$745M
| $76.7K | ﹤0.01% |
25,551
-2,582
|
|
||
1743
Personalis
PSNL
$1.19B
| $76.1K | ﹤0.01% |
11,950
-1,131
|
|
||
|
NB
1744
NioCorp Developments
NB
$840M
| $76K | ﹤0.01% |
17,042
-2,522
|
|
||
1745
Altimmune
ALT
$593M
| $75.5K | ﹤0.01% |
24,523
+3,707
|
|
||
1746
Vanda Pharmaceuticals
VNDA
$388M
| $74.2K | ﹤0.01% |
10,731
-2,058
|
|
||
1747
Lexeo Therapeutics
LXEO
$404M
| $73.8K | ﹤0.01% |
12,852
-1,900
|
|
||
1748
AMC Entertainment Holdings
AMC
$1.3B
| $73.4K | ﹤0.01% |
74,930
-19,548
|
|
||
1749
Atea Pharmaceuticals
AVIR
$374M
| $73.4K | ﹤0.01% |
13,638
-2,802
|
|
||
1750
ASP Isotopes
ASPI
$980M
| $72.8K | ﹤0.01% |
16,481
-423
|
|